{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:40Z","timestamp":1791475480305,"version":"4.3.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Huazhi-Rougan (HZRG) formula is a Traditional Chinese medicine prescription, and has been widely used to treat non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH). However, the anti-NASH effects and the underlying mechanisms of HZRG have not yet been characterized. Here we showed that 4-week HZRG treatment alleviated methionine-choline-deficiency (MCD) diet-induced NASH in C57BL\/6J mice, as evidenced by the improvement of hepatic steatosis and inflammation, as well as the decrease of serum levels of alanine and aspartate transaminases. Fecal 16S rDNA sequencing indicated that HZRG reduced the enrichment of pathogenic bacteria and increased the abundance of bacteria gena that are involved in bile acid (BA) conversation. The alteration of fecal and serum BA profile suggested that HZRG enhanced fecal BA excretion, and reduced the reabsorption of toxic secondary BA species (LCA, DCA, HCA). We further analyzed the BA receptors and transporters, and found that HZRG inhibited the expression of ileal bile acid transporter, and organic solute transporter subunit \u03b2, and increased the expression of intestinal tight junction proteins (ZO-1, Occludin, Claudin-2). The modulation of gut dysbiosis and BA profile, as well as the improvement of the intestinal environment, may contribute to the decrease of the p-65 subunit of NF-\u03baB phosphorylation, liver F4\/80 positive macrophages, inflammatory cytokine IL-1\u03b2 and TNF-\u03b1 expression. In conclusion, HZRG treatment enhances fecal BA excretion <jats:italic>via<\/jats:italic> inhibiting BA transporters, modulates BA profiles, gut dysbiosis as well as the intestinal environment, thus contributing to the beneficial effect of HZRG on NASH mice.<\/jats:p>","DOI":"10.3389\/fphar.2022.833414","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T14:13:36Z","timestamp":1654092816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Medicinal Formula Huazhi-Rougan Attenuates Non-Alcoholic Steatohepatitis Through Enhancing Fecal Bile Acid Excretion in Mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunlin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current Concepts and Future Challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/17474124.2018.1522248","article-title":"Elobixibat for the Treatment of Constipation","volume":"12","author":"Chedid","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13073-021-00869-z","article-title":"Microbiota-associated Risk Factors for Asymptomatic Gut Colonisation with Multi-Drug-Resistant Organisms in a Dutch Nursing Home","volume":"13","author":"Ducarmon","year":"2021","journal-title":"Genome Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jnutbio.2015.01.002","article-title":"Reshaping Faecal Gut Microbiota Composition by the Intake of Trans-resveratrol and Quercetin in High-Fat Sucrose Diet-Fed Rats","volume":"26","author":"Etxeberria","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile Acid Signaling in Inflammatory Bowel Diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41401-018-0195-3","article-title":"A Novel ASBT Inhibitor, IMB17-15, Repressed Nonalcoholic Fatty Liver Disease Development in High-Fat Diet-Fed Syrian Golden Hamsters","volume":"40","author":"Ge","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/nu13072135","article-title":"Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring","volume":"13","author":"Guo","year":"2021","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02535021","article-title":"Effects of Feeding Chenodeoxycholic Acid on Metabolism of Cholesterol and Bile Acids in Germ-free Rats","volume":"16","author":"Gustafsson","year":"1981","journal-title":"Lipids"},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpba.2019.04.001","article-title":"In Vivo metabolic Profiles of Bu-Zhong-Yi-Qi-Tang, a Famous Traditional Chinese Medicine Prescription, in Rats by Ultra-high-performance Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Tandem Mass Spectrometry","volume":"171","author":"Hu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12072-020-10070-w","article-title":"Ileal Bile Acid Transporter Inhibition as an Anticholestatic Therapeutic Target in Biliary Atresia and Other Cholestatic Disorders","volume":"14","author":"Karpen","year":"2020","journal-title":"Hepatol. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"111587","DOI":"10.1016\/j.biopha.2021.111587","article-title":"Salvia-Nelumbinis Naturalis Extract Protects Mice against MCD Diet-Induced Steatohepatitis via Activation of Colonic FXR-FGF15 Pathway","volume":"139","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","article-title":"Bile Acid-Based Therapies for Non-alcoholic Steatohepatitis and Alcoholic Liver Disease","volume":"9","author":"Li","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.chom.2007.06.01010.1016\/j.chom.2007.08.002","article-title":"Host-mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jnutbio.2015.10.014","article-title":"Diets Enriched with Cranberry Beans Alter the Microbiota and Mitigate Colitis Severity and Associated Inflammation","volume":"28","author":"Monk","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"154925","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the Molecular Targets and Emerging Pharmacotherapeutic Interventions for Nonalcoholic Fatty Liver Disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1172\/JCI119355","article-title":"Primary Bile Acid Malabsorption Caused by Mutations in the Ileal Sodium-dependent Bile Acid Transporter Gene (SLC10A2)","volume":"99","author":"Oelkers","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/imm.13028","article-title":"Interleukin-17\/interleukin-17 Receptor axis Elicits Intestinal Neutrophil Migration, Restrains Gut Dysbiosis and Lipopolysaccharide Translocation in High-Fat Diet-Induced Metabolic Syndrome Model","volume":"156","author":"P\u00e9rez","year":"2019","journal-title":"Immunology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00176-20","DOI":"10.1128\/mSystems.00176-20","article-title":"Increasing the Hindgut Carbohydrate\/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism to Stimulate Colonic Barrier Function","volume":"5","author":"Pi","year":"2020","journal-title":"mSystems"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The Organic Solute Transporter Alpha-Beta, Ostalpha-Ostbeta, Is Essential for Intestinal Bile Acid Transport and Homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of Ileal Bile Acid Uptake Protects against Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fmed.2020.00060","article-title":"Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice","volume":"7","author":"Rao","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile Salt Biotransformations by Human Intestinal Bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0218459","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical Sodium-dependent Bile Acid Transporter Inhibition with Volixibat Improves Metabolic Aspects and Components of Non-alcoholic Steatohepatitis in Ldlr-\/-.Leiden Mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"750826","DOI":"10.3389\/fphar.2021.750826","article-title":"Berberine Alleviates Non-alcoholic Steatohepatitis through Modulating Gut Microbiota Mediated Intestinal FXR Activation","volume":"12","author":"Shu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/gutjnl-2019-318811","article-title":"Intrahepatic Bacterial Metataxonomic Signature in Non-alcoholic Fatty Liver Disease","volume":"69","author":"Sookoian","year":"2020","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ana.25250","article-title":"Age-related Changes in the Gut Microbiota Influence Systemic Inflammation and Stroke Outcome","volume":"84","author":"Spychala","year":"2018","journal-title":"Ann. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","article-title":"Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC","volume":"11","author":"Sydor","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-014-0214-1","article-title":"Is Serum Interleukin-17 Associated with Early Atherosclerosis in Obese Patients?","volume":"12","author":"Tarantino","year":"2014","journal-title":"J. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000450982","article-title":"Crosstalk between Bile Acids and Gut Microbiota and its Impact on Farnesoid X Receptor Signalling","volume":"35","author":"Wahlstr\u00f6m","year":"2017","journal-title":"Dig. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12969","DOI":"10.21037\/apm-20-1613","article-title":"Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Fatty Liver: a Systematic Review and Meta-Analysis","volume":"10","author":"Wang","year":"","journal-title":"Ann. Palliat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/sjg.SJG_462_20","article-title":"Clinical Effects of Ursodeoxycholic Acid on Patients with Ulcerative Colitis May Improve via the Regulation of IL-23-IL-17 axis and the Changes of the Proportion of Intestinal Microflora","volume":"27","author":"Wang","year":"2021","journal-title":"Saudi J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12072-020-10107-0","article-title":"Elobixibat, an Ileal Bile Acid Transporter Inhibitor, Ameliorates Non-alcoholic Steatohepatitis in Mice","volume":"15","author":"Yamauchi","year":"2021","journal-title":"Hepatol. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.833414\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T14:13:38Z","timestamp":1654092818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.833414\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":35,"alternative-id":["10.3389\/fphar.2022.833414"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.833414","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"833414"}}